Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three-month periods ended March 31, 2021 and 2020, were as follows (in thousands):

	Three Months Ended
	March 31,
	2021		2020
Net Sales
Cardiovascular	$	241,006	$	235,544
Endoscopy		7,907		7,981
Total net sales		248,913		243,525
Operating Income (Loss)
Cardiovascular		12,201		1,502
Endoscopy		1,993		(140)
Total operating income		14,194		1,362
Total other expense - net		(1,500)		(3,354)
Income tax expense		1,736		1,162
Net income (loss)	$	10,958	$	(3,154)